Bioventix (LON:BVXP) Trading Down 2.6% – What’s Next?

Bioventix PLC (LON:BVXP) shares were down 2.6% during trading on Friday . The company traded as low as GBX 3,450 ($43.54) and last traded at GBX 3,456 ($43.62). Approximately 7,664 shares changed hands during mid-day trading, an increase of 31% from the average daily volume of 5,833 shares. The stock had previously closed at GBX 3,550 ($44.81).

Bioventix Trading Down 2.6 %

The business has a 50 day simple moving average of GBX 3,712.29 and a two-hundred day simple moving average of GBX 4,034.04. The stock has a market cap of £180.40 million, a price-to-earnings ratio of 2,120.25 and a beta of 0.35.

Bioventix Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, November 21st. Stockholders of record on Thursday, November 7th were given a dividend of GBX 87 ($1.10) per share. The ex-dividend date of this dividend was Thursday, November 7th. This represents a dividend yield of 2.4%. This is an increase from Bioventix’s previous dividend of $68.00. Bioventix’s dividend payout ratio (DPR) is presently 9,693.25%.

Insider Buying and Selling

In other news, insider Bruce Hiscock purchased 24 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The stock was acquired at an average cost of GBX 3,822 ($48.24) per share, for a total transaction of £917.28 ($1,157.74). Insiders own 8.02% of the company’s stock.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.